Top Nav

Best Entry in 10 Months for Bristol Myers Squibb

Andy Crowder

It may not be a fancy company.  And it’s not your typical stock to trade.  But Bristol Myers Squibb Company (NYSE: BMY) is perfectly positioned to rally. In fact, this is the best opportunity in 10 months to own one of Wall Street’s top pharma companies.

The secret of this trade is watching the 200-day moving average like a hawk. The 200-day is a place where big money often invests. Look at the last two rallies (blue circles) that started at this moving average.

The first rally was in March, as the shares shot 21% higher to $28.85 from $23.66. The second rally began in August at $24.93, where the shares exploded 40% higher.

I see the optimal entry as $31.76. Based on the past, Bristol Myers Squibb stock is poised to rocket higher over the next few months.

Equities mentioned in this article: BMY

Strike Price Offer

The Strike Price is your leading resource for insight into the world of options trading. Chief options analyst Andy Crowder will guide you through the best options strategies—telling you exactly where he's putting his money, and how you can make safe, reliable gains from some simple options trades. Your FREE subscription also includes Andy’s report "The One Vital Rule for Every Options Trade"—which reveals the #1 rule to achieve a high win-rate in every options trade.
You've successfully subscribed, click the link in your email to confirm your subscription.
There was an error, and you have not been subscribed, please try again.